Maurice Julian Berkowitz MD MS

Summary

• Maurice J. Berkowitz, MD, MSc, is a Clinical Professor of Medicine in the Division of Hematology/Oncology at UCLA, where his clinical and academic work focuses on breast cancer. He is actively involved in the care of patients across the spectrum of breast cancer, with an emphasis on integrating emerging diagnostics, targeted therapies, and precision oncology into clinical practice.
  
  His academic research interests center on circulating tumor DNA (ctDNA) and other technologies designed to detect molecular residual disease, monitor treatment response, identify recurrence earlier, and ultimately improve the personalization of cancer therapy. He has a particular interest in translating rapidly evolving advances in breast cancer research into meaningful improvements in patient care.
  
  Dr. Berkowitz is also the founder of MyCANDOR, a nonprofit organization dedicated to closing gaps in cancer care, education, and access. Through MyCANDOR, he leads initiatives focused on breast cancer education and improving access to contemporary cancer information for patients and communities, including bilingual educational outreach across the Americas.
  
  MyCANDOR’s work also includes cervical cancer prevention through HPV education, vaccination, screening, and collaborative initiatives designed to expand access to evidence-based prevention strategies in underserved communities. Across his clinical, academic, and nonprofit work, Dr. Berkowitz is committed to connecting scientific innovation with practical, equitable cancer care.